SYNACT.ST STO
SynAct Pharma AB
1W: +2.9%
1M: +2.1%
3M: -7.8%
YTD: -13.6%
1Y: -3.5%
3Y: -82.2%
5Y: -83.8%
kr 17.80 ($1.77)
+0.62 (+3.61%)
Weekly Expected Move ±6.3%
kr 16
kr 17
kr 18
kr 19
kr 20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$89M
+11.0% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$89M
+11.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
+97.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$31M | -$77M | -$106M | -$216M | -$90M |
| Depreciation & Amort. | $0 | $88K | $1M | $75M | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $8M | $0 |
| Change in Working Capital | -$3M | $7M | -$20M | $30M | -$18M |
| Other Non-Cash Items | $815K | $5M | $7M | $85M | $19M |
| Operating Cash Flow | -$33M | -$65M | -$118M | -$100M | -$89M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$93K | -$6K | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $27K | $370K | $0 |
| Investing Cash Flow | -$93K | -$6K | $27K | $370K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$77K | -$981K | -$729K | -$596K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$5M | -$6M | -$27M | -$5M | -$6M |
| Financing Cash Flow | $45M | $74M | $201M | $54M | $87M |
| Net Change in Cash | $11M | $9M | $84M | -$46M | -$1M |
| Cash End of Period | $15M | $24M | $108M | $62M | $61M |
| Free Cash Flow | -$33M | -$65M | -$118M | -$100M | -$89M |